Type 2 Diabetes Trial, Not Yet Recruiting NCT07577063 Sponsor: Coordinación de Investigación en Salud, Mexico Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07577063
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 18 and 65 years of age
  • People who have not previously been diagnosed with type 2 diabetes or high blood pressure
  • People who receive their regular healthcare at a Mexican Social Security Institute (IMSS) or IMSS-Bienestar primary health centre
  • People who are willing and able to give their informed agreement to take part in the study
  • People who are willing to attend an initial assessment and yearly follow-up check-ins

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have already been diagnosed with type 2 diabetes or high blood pressure
  • People who are pregnant at the time of enrolment
  • People who have a condition that limits their ability to complete study procedures, including a six-minute walking test
  • People who have any condition that the study investigators believe may interfere with their participation or follow-up (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rodolfo Rivas, PhD, Instituto Mexicano del Seguro Social

Phone: +52 5556276900

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Coordinación de Investigación en Salud, Mexico
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 August 2031

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Incidence of Type 2 Diabetes Mellitus; Incidence of Hypertension

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov